리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 186 Pages
라이선스 & 가격 (부가세 별도)
한글목차
혈관 스텐트 세계 시장은 2030년까지 133억 달러에 이를 전망
2023년에 100억 달러로 추정되는 혈관 스텐트 세계 시장은 2023-2030년간 CAGR 4.2%로 성장하여 2030년에는 133억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 풍선 확장형 스텐트는 CAGR 4.9%를 나타내고, 분석 기간 종료까지 92억 달러에 이를 것으로 예측됩니다. 자기 확장형 스텐트 부문의 성장률은 분석 기간중 CAGR 2.9%로 추정됩니다.
미국 시장은 27억 달러, 중국은 CAGR 7.8%로 성장할 것으로 예측
미국 혈관 스텐트 시장은 2023년에 27억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2023년부터 2030년까지의 분석 기간에 CAGR 7.8%로 성장을 지속하여, 2030년까지 30억 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.3%와 4.5%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.6%로 성장할 것으로 예측됩니다.
세계 혈관 스텐트 시장 - 주요 동향 및 촉진요인 정리
혈관 스텐트가 혈관 질환 치료에 필수적인 이유는 무엇인가?
혈관 스텐트는 관상동맥질환, 말초동맥질환, 동맥류 등 다양한 혈관질환 치료의 핵심이 되고 있습니다. 좁아지거나 막힌 혈관을 열어 적절한 혈류를 회복시켜 심장마비나 뇌졸중과 같은 합병증을 예방하는 데 사용됩니다. 고령화, 좌식 생활, 비만 및 당뇨병 증가 등의 요인으로 인해 혈관 질환의 발생률이 증가함에 따라 혈관 스텐트에 대한 수요가 증가하고 있습니다. 의료진이 환자의 예후를 개선하고 폐색 재발의 위험을 줄이기 위해 노력하면서 첨단 스텐트 기술의 채택이 가속화되어 시장을 주도하고 있습니다.
기술 혁신은 혈관 스텐트 시장에 어떤 영향을 미치고 있는가?
기술 혁신은 혈관 스텐트 시장에 큰 영향을 미치고 있으며, 보다 효과적이고 안전하며 내구성이 뛰어난 장치를 개발할 수 있는 기회를 제공합니다. 재협착을 예방하는 약물을 방출하는 약물 용출 스텐트(DES)의 도입은 이 분야에 혁명을 일으켜 재수술의 필요성을 줄이고 환자의 장기적인 예후를 개선했습니다. 또한, 생체 흡수성 스텐트가 개발되어 기능을 수행하면 서서히 용해되는 것은 영구적 임플란트에 수반되는 장기적인 합병증을 줄이는 데 큰 진전을 이루었습니다. 또한 코발트 크롬 합금, 백금 크롬 합금과 같은 첨단 재료의 사용으로 스텐트의 유연성, 강도 및 방사선 투과성이 개선되어 복잡한 해부학적 구조에서도 보다 정확한 배치와 우수한 성능을 발휘할 수 있게 되었습니다. 이러한 기술 발전은 혈관 질환 치료에 큰 이점을 가져다주어 혈관 스텐트의 보급을 촉진하고 있습니다.
혈관 스텐트의 새로운 동향은?
혈관 스텐트 시장은 미래를 좌우할 몇 가지 새로운 트렌드를 목격하고 있습니다. 그 중 하나는 최소침습 수술에 대한 선호도가 높아지면서 작은 절개창을 통해 높은 정확도로 전달할 수 있는 스텐트에 대한 수요가 증가하고 있다는 점입니다. 스텐트와 함께 사용되는 약물 코팅 풍선(DCB) 증가는 재협착을 억제하고 환자의 예후를 개선하기 위한 보완적인 접근법을 제공하는 트렌드 중 하나입니다. 또한, 당뇨병 환자나 복잡한 혈관 구조를 가진 환자 등 특정 환자군을 위한 스텐트 개발에도 많은 관심이 집중되고 있어, 보다 개인화된 치료 옵션이 늘어나고 있습니다. 또한, 베어 메탈 스텐트와 약물 용출 스텐트의 장점을 결합한 하이브리드 스텐트에 대한 관심이 높아지면서 장기적인 안전성과 유효성의 균형을 제공하는 하이브리드 스텐트에 대한 시장 발전에도 영향을 미치고 있습니다.
혈관 스텐트 시장의 성장을 가속하는 요인은 무엇인가?
혈관 스텐트 시장의 성장은 전 세계 이환율과 사망률의 주요 원인인 혈관 질환의 유병률 증가와 같은 여러 요인에 의해 주도되고 있습니다. 또한, 환자의 회복 시간, 입원 기간, 의료비 절감의 필요성으로 인해 최소침습적 시술에 대한 수요가 증가하고 있는 것도 시장 성장의 원동력이 되고 있습니다. 또한 약물 용출성 스텐트, 생체 흡수성 스텐트, 하이브리드 스텐트 등 스텐트 기술의 지속적인 발전으로 의료진이 이용할 수 있는 치료 옵션이 확대되고 있습니다. 환자 개개인의 필요에 맞는 치료의 중요성을 강조하는 맞춤의료에 대한 관심이 높아지면서 첨단 스텐트 채택을 더욱 촉진하고 있습니다. 또한, 의료 인프라의 개선과 심혈관 건강에 대한 인식이 높아짐에 따라 신흥 시장에서 혈관 스텐트의 가용성이 증가하면서 시장 확대에 기여하고 있습니다.
조사 대상 기업 예(주목 26개사)
Abbott Laboratories, Inc.
B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Biotronik SE & Co. KG
Boston Scientific Corporation
Endologix, Inc.
Jotec GmbH
Lombard Medical Technologies, Inc.
Medtronic PLC
Meril Life Sciences Pvt., Ltd.
MicroPort Scientific Corporation
Terumo Corporation
Translumina GmbH
Vascular Concepts Ltd.
W.L. Gore & Associates, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Vascular Stents Market to Reach US$13.3 Billion by 2030
The global market for Vascular Stents estimated at US$10.0 Billion in the year 2023, is expected to reach US$13.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Balloon-Expandable Stents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$9.2 Billion by the end of the analysis period. Growth in the Self-Expandable Stents segment is estimated at 2.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.8% CAGR
The Vascular Stents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.0 Billion by the year 2030 trailing a CAGR of 7.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.
Global Vascular Stents Market - Key Trends & Drivers Summarized
Why Are Vascular Stents Crucial in Treating Vascular Diseases?
Vascular stents have become a cornerstone in the treatment of various vascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms. These devices are used to open narrowed or blocked blood vessels, restoring proper blood flow and preventing complications such as heart attacks or strokes. The rising incidence of vascular diseases, driven by factors such as aging populations, sedentary lifestyles, and increasing rates of obesity and diabetes, has led to a growing demand for vascular stents. As medical practitioners seek to improve patient outcomes and reduce the risk of recurrent blockages, the adoption of advanced stent technologies has accelerated, driving the market forward.
How Are Technological Innovations Impacting the Vascular Stents Market?
Technological innovations have significantly impacted the vascular stents market, leading to the development of more effective, safe, and durable devices. The introduction of drug-eluting stents (DES), which release medication to prevent restenosis, has revolutionized the field, reducing the need for repeat procedures and improving long-term patient outcomes. Additionally, the development of bioresorbable stents, which gradually dissolve after fulfilling their function, represents a major advancement in reducing long-term complications associated with permanent implants. The use of advanced materials, such as cobalt-chromium and platinum-chromium alloys, has also improved the flexibility, strength, and radiopacity of stents, allowing for more precise placement and better performance in complex anatomies. These technological advancements are driving the widespread adoption of vascular stents, as they offer significant benefits in the treatment of vascular diseases.
What Are the Emerging Trends in Vascular Stents?
The vascular stents market is witnessing several emerging trends that are shaping its future. One key trend is the growing preference for minimally invasive procedures, which are driving the demand for stents that can be delivered through smaller incisions with greater precision. The rise in the use of drug-coated balloons (DCBs) in combination with stents is another trend, offering a complementary approach to reducing restenosis and improving patient outcomes. The market is also seeing an increased focus on the development of stents for specific patient populations, such as those with diabetes or complex vascular anatomies, leading to more personalized treatment options. Additionally, the growing interest in hybrid stents, which combine the benefits of both bare-metal and drug-eluting stents, is influencing the market's evolution, as these devices offer a balance between long-term safety and efficacy.
What Factors Are Driving the Growth of the Vascular Stents Market?
The growth in the vascular stents market is driven by several factors, including the increasing prevalence of vascular diseases, which are major contributors to global morbidity and mortality. The rising demand for minimally invasive procedures, driven by the need to reduce patient recovery times, hospital stays, and healthcare costs, is also fueling market growth. Additionally, the continuous advancements in stent technology, including the development of drug-eluting, bioresorbable, and hybrid stents, are expanding the range of treatment options available to healthcare providers. The growing focus on personalized medicine, which emphasizes the importance of tailoring treatments to individual patient needs, is further boosting the adoption of advanced stents. Moreover, the increasing availability of vascular stents in emerging markets, supported by improving healthcare infrastructure and rising awareness of cardiovascular health, is contributing to the market's expansion.
Select Competitors (Total 26 Featured) -
Abbott Laboratories, Inc.
B. Braun Melsungen AG
BARD, A Becton, Dickinson Company
Biotronik SE & Co. KG
Boston Scientific Corporation
Endologix, Inc.
Jotec GmbH
Lombard Medical Technologies, Inc.
Medtronic PLC
Meril Life Sciences Pvt., Ltd.
MicroPort Scientific Corporation
Terumo Corporation
Translumina GmbH
Vascular Concepts Ltd.
W.L. Gore & Associates, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Vascular Stents - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Technological Advancements in Drug-Eluting Stents
Growing Adoption of Bioabsorbable and Biodegradable Stents
Increasing Incidence of Coronary Artery Disease Driving Demand
Expansion of Stent Applications in Peripheral Artery Disease
Innovations in Stent Design for Improved Efficacy and Safety
Rising Demand for Minimally Invasive Vascular Procedures
Impact of Aging Population on Stent Market Growth
Focus on Reducing Restenosis Rates Post Stenting
Growing Use of Imaging-guided Stent Placement Techniques
Impact of Healthcare Reimbursement Policies on Stent Adoption
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Coronary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Peripheral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Evar Graft Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Evar Graft Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Evar Graft Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Vascular Stents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 14: World Recent Past, Current & Future Analysis for Balloon-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for Balloon-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for Balloon-Expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Self-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Self-Expandable Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Self-Expandable Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Vascular Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 77: France Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 86: Germany Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Germany 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Italy 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 104: UK Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: UK 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SPAIN
TABLE 113: Spain Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Spain Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Spain 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 116: Spain Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Spain Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Spain 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 119: Spain Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
RUSSIA
TABLE 122: Russia Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Russia Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Russia 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 125: Russia Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Russia Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Russia 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 128: Russia Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Europe 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Europe 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Vascular Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Asia-Pacific 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
AUSTRALIA
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 152: Australia Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Australia Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Australia 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 155: Australia Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Australia Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Australia 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 158: Australia Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
INDIA
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 161: India Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: India Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: India 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 164: India Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: India Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: India 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 167: India Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 170: South Korea Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: South Korea Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: South Korea 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 173: South Korea Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: South Korea Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: South Korea 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 176: South Korea Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Asia-Pacific Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of Asia-Pacific Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
LATIN AMERICA
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 188: Latin America Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 189: Latin America Historic Review for Vascular Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Latin America 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 191: Latin America Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Latin America Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Latin America 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 194: Latin America Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 200: Argentina Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Argentina Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Argentina 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 203: Argentina Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Argentina Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Argentina 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 206: Argentina Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
BRAZIL
TABLE 209: Brazil Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Brazil Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Brazil 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 212: Brazil Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Brazil Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Brazil 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 215: Brazil Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
MEXICO
TABLE 218: Mexico Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Mexico Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Mexico 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 221: Mexico Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Mexico Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Mexico 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 224: Mexico Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Rest of Latin America Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Rest of Latin America 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Rest of Latin America Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Rest of Latin America 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
MIDDLE EAST
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 236: Middle East Recent Past, Current & Future Analysis for Vascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 237: Middle East Historic Review for Vascular Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Middle East 16-Year Perspective for Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 239: Middle East Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Middle East Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Middle East 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 242: Middle East Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
IRAN
TABLE 248: Iran Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Iran Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Iran 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 251: Iran Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Iran Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Iran 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 254: Iran Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
ISRAEL
TABLE 257: Israel Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Israel Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Israel 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 260: Israel Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Israel Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Israel 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 263: Israel Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Saudi Arabia Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Saudi Arabia 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Saudi Arabia Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Saudi Arabia 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 275: UAE Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: UAE Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: UAE 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 278: UAE Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: UAE Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: UAE 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 281: UAE Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: Rest of Middle East Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: Rest of Middle East 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: Rest of Middle East Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: Rest of Middle East 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
AFRICA
Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 293: Africa Recent Past, Current & Future Analysis for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Africa Historic Review for Vascular Stents by Type - Balloon-Expandable Stents and Self-Expandable Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Africa 16-Year Perspective for Vascular Stents by Type - Percentage Breakdown of Value Sales for Balloon-Expandable Stents and Self-Expandable Stents for the Years 2014, 2024 & 2030
TABLE 296: Africa Recent Past, Current & Future Analysis for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Africa Historic Review for Vascular Stents by Product - Coronary, Peripheral and Evar Graft Stents Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Africa 16-Year Perspective for Vascular Stents by Product - Percentage Breakdown of Value Sales for Coronary, Peripheral and Evar Graft Stents for the Years 2014, 2024 & 2030
TABLE 299: Africa Recent Past, Current & Future Analysis for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Vascular Stents by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Vascular Stents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030